CRA Insights

IP Literature Watch: February 2022

February 24, 2022
Stack of books on a table

Among the papers featured in this month’s IP Literature Watch are a paper examining  how the US Patent Office has dealt with antibody patents over approximately two decades; an article explaining how the standard developed in the Supreme Court’s Actavis decision can be adapted and applied to trademark cases; a paper exploring whether the simultaneous release of information affects managers’ ability to gather decision-relevant information from market prices; an article that addresses whether Congress has the authority to issue patents on AI-produced inventions; and an article from CRA Life Sciences consultants examining the role of the TRIPS Agreement in encouraging diffusion of pharmaceutical technology to developing countries.

To read more about these topics and other recent publications concerning intellectual property issues around the world, download a copy.

Meet the authors

Additional contributors